Monday, September 11, 2023 2:21:25 PM
Just a heads up... Research to come but... Good to know...
Crinetics Pharmaceuticals Inc. $CRNX is up BIG today
The Pharm Company stated that, Paltusotine, its experimental treatment for rare hormonal disorder called Acromegaly succeeded in a late-stage trial.
Sunday, Crinetics stated 83% of patients treated with paltusotine had the ability maintain growth-factor levels vs the opposite end, 4% of patients receiving the placebo.
Another late-stage trial will be conducted in 2024 Q1, the company said that it intends to submit an application to seek approval for paltusotine from the FDA next year.
OI on CvP's. wow.
https://www.advfn.com/stock-market/NASDAQ/CRNX/options?expiry=20231020&strikes=50
Crinetics Pharmaceuticals Inc. $CRNX is up BIG today
The Pharm Company stated that, Paltusotine, its experimental treatment for rare hormonal disorder called Acromegaly succeeded in a late-stage trial.
Sunday, Crinetics stated 83% of patients treated with paltusotine had the ability maintain growth-factor levels vs the opposite end, 4% of patients receiving the placebo.
Another late-stage trial will be conducted in 2024 Q1, the company said that it intends to submit an application to seek approval for paltusotine from the FDA next year.
OI on CvP's. wow.
https://www.advfn.com/stock-market/NASDAQ/CRNX/options?expiry=20231020&strikes=50
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
